Paris Cardiovascular Research Center, INSERM U970, Université Paris Descartes, 56 rue Leblanc, 75015 Paris, France.
Arterioscler Thromb Vasc Biol. 2012 Mar;32(3):643-53. doi: 10.1161/ATVBAHA.111.244392. Epub 2012 Jan 19.
Catecholamines have been shown to control bone marrow (BM)-derived cell egress, yet the cellular and molecular mechanisms involved in this effect and their subsequent participation to postischemic vessel growth are poorly understood.
Tyrosine hydroxylase mRNA levels, as well as dopamine (DA) and norepinephrine (NE) contents, were increased in the ischemic BM of mice with right femoral artery ligation. Angiographic score, capillary density, and arteriole number were markedly increased by treatments with DA (IP, 50 mg/kg, 5 days) or NE (IP, 2.5 mg/kg, 5 days). Using chimeric mice lethally irradiated and transplanted with BM-derived cells from green fluorescent protein mice, we showed that DA and NE enhanced by 70% (P<0.01) and 62% (P<0.001), respectively, the number of green fluorescent protein-positive BM-derived cells in ischemic tissue and promoted their ability to differentiate into cells with endothelial and inflammatory phenotypes. Similarly, both DA and NE increased the in vitro differentiation of cultured BM-derived cells into cells with endothelial phenotype. This increase was blunted by the nitric oxide synthase inhibitor Nω-nitro-L-arginine methyl ester. DA and NE also upregulated the number of CD45-positive cells in blood 3 days after ischemia and that of macrophages in ischemic tissue 21 days after ischemia. Of interest, DA and NE increased BM endothelial nitric oxide synthase (eNOS) mRNA levels and were unable to promote BM-derived cell mobilization in chimeric eNOS-deficient mice lethally irradiated and transplanted with BM-derived cells from wild-type animals. Furthermore, administration of a β2 adrenergic agonist (clenbuterol, IP, 2 mg/kg, 5 days) and that of a dopaminergic D1/D5 receptor agonist (SKF-38393, IP, 2.5 mg/kg, 5 days) also enhanced BM-derived cell mobilization and subsequently postischemic vessel growth. CONCLUSION These results unravel, for the first time, a major role for the sympathetic nervous system in BM-derived cell egress through stromal eNOS activation.
儿茶酚胺已被证明可以控制骨髓(BM)衍生细胞的流出,但涉及这种效应的细胞和分子机制及其随后对缺血后血管生长的参与仍知之甚少。
在右侧股动脉结扎的小鼠缺血 BM 中,酪氨酸羟化酶 mRNA 水平以及多巴胺(DA)和去甲肾上腺素(NE)含量增加。用 DA(IP,50mg/kg,5 天)或 NE(IP,2.5mg/kg,5 天)处理可显著增加血管造影评分、毛细血管密度和小动脉数量。使用致死性辐照并移植来自绿色荧光蛋白小鼠的 BM 衍生细胞的嵌合小鼠,我们表明 DA 和 NE 分别增加了 70%(P<0.01)和 62%(P<0.001)缺血组织中绿色荧光蛋白阳性 BM 衍生细胞的数量,并促进其分化为具有内皮和炎症表型的细胞的能力。同样,DA 和 NE 均增加了体外培养的 BM 衍生细胞向具有内皮表型的细胞的分化。这种增加被一氧化氮合酶抑制剂 Nω-硝基-L-精氨酸甲酯减弱。DA 和 NE 还增加了缺血后 3 天血液中 CD45 阳性细胞的数量和缺血后 21 天缺血组织中巨噬细胞的数量。有趣的是,DA 和 NE 增加了 BM 内皮型一氧化氮合酶(eNOS)mRNA 水平,并且在接受致死性辐照并移植来自野生型动物的 BM 衍生细胞的嵌合 eNOS 缺陷型小鼠中无法促进 BM 衍生细胞的动员。此外,β2 肾上腺素能激动剂(克仑特罗,IP,2mg/kg,5 天)和多巴胺 D1/D5 受体激动剂(SKF-38393,IP,2.5mg/kg,5 天)的给药也增强了 BM 衍生细胞的动员,随后促进了缺血后血管的生长。
这些结果首次揭示了交感神经系统通过基质 eNOS 激活在 BM 衍生细胞流出中的主要作用。